Novo Nordisk’s once‐weekly injectable, Ozempic (semaglutide), originally developed for type 2 diabetes, has increasingly ...
The Department of Health in KwaZulu-Natal has blamed a shortage of insulin on the global Ozempic frenzy. The medication, ...
Meanwhile, Mounjaro (tirzepatide) is a brand-name subcutaneous injection pen also used to treat type 2 diabetes. Mounjaro: ...